RecruitingNCT02315729

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis


Sponsor

University of Colorado, Denver

Enrollment

380 participants

Start Date

Nov 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to identify potential markers for curve progression in adolescent idiopathic scoliosis (AIS). Despite its prevalence and impact on child health, the etiology of AIS and molecular mechanisms underlying its development and progression remain poorly understood. Clinical criteria and features cannot adequately predict which children, diagnosed with mild disease, will undergo subsequent curve progression requiring intervention. The investigators hypothesize that alterations in specific genetic markers will be correlated with the progression of AIS curves over time. Thus, these markers could be used in the future to develop a reliable, inexpensive and relatively non-invasive cell based diagnostic test to (1) predict spinal curve progression in AIS, (2) select patients likely to benefit from early surgical intervention, and (3) potentially screen for asymptomatic children at risk of developing idiopathic scoliosis.


Eligibility

Sex: FEMALEMin Age: 10 YearsMax Age: 13 Years

Inclusion Criteria2

  • Females aged 10-13 years
  • Diagnosed with mild-moderate spine deformity (Cobb angle 15-30 degrees)

Exclusion Criteria6

  • Patients with scoliosis other than idiopathic
  • Trauma
  • Inflammatory disease
  • Malignancies
  • Diabetes
  • History of previous spine surgery

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Children'S Hospital of Colorado

Denver, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02315729


Related Trials